View More View Less
  • 1 Urology and Nephrology Research Center, Shahid Labbafinejad Hospital, Shahid Beheshti University of Medical Sciences, Iran
  • | 2 Department of Microbiology, School of Medicine, Shahid Beheshti University of Medical Sciences, Iran
  • | 3 Department of Microbiology, School of Medicine, Iran University of Medical Sciences, Iran
Restricted access

Purchase article

USD  $25.00

1 year subscription (Individual Only)

USD  $784.00

Urinary tract infection (UTI) is a common type of infectious disease globally. The aim of this study was to detect the frequency of fosA3 and fosC2 genes in extended-spectrum β-lactamases (ESBL) and blaDHA, blaCMY-2, and blaCMY-42 genes in AmpC β-lactamases-producing isolates of Escherichia coli. In total, 120 isolates of E. coli were collected from three teaching hospitals between March 2014 and February 2015. Antibiotic susceptibility tests were carried out by disk diffusion method. The presence of blaCMY-2, blaCMY-42, blaDHA, fosA3, and fosC2 genes was detected by polymerase chain reaction (PCR) and sequencing. Of the 120 strains, 92 (76.6%) were identified as ESBL producers, 30 (25%) were determined as AmpC β-lactamase producers, and 24 (20%) had both ESBL and AmpC β-lactamase enzymes. Imipenem, fosfomycin, and nitrofurantoin had the best effect against isolates of E. coli. PCR assay demonstrated that the frequency of blaCMY-2, blaCMY-42, and blaDHA genes among AmpC β-lactamases-producing strains were 39%, 1%, and 17.5%, respectively. This study reports the first detection of fosfomycin resistance in Iran. This study indicated the increasing prevalence of UTI isolates of E. coli-harboring ESBL and AmpC β-lactamases genes in Iran. Therefore, due to the high rate of blaDHA and blaCMY genes and emergence of fosfomycin-resistant E. coli isolates, we recommend continuous monitoring of antibiotic resistance as well as attention to guidelines of infection controls.

  • 1.

    Zowawi, H. M., Harris, P. N., Roberts, M. J., Tambyah, P. A., Schembri, M. A., Pezzani, M. D., Williamson, D. A., Paterson, D. L.: The emerging threat of multidrug-resistant Gram-negative bacteria in urology. Nat Rev Urol 12, 570584 (2015).

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 2.

    Heidary, M., Bahramian, A., Hashemi, A., Goudarzi, M., Omrani, V. F., Eslami, G., Goudarzi, H.: Detection of acrA, acrB, aac (6′)-Ib-cr, and qepA genes among clinical isolates of Escherichia coli and Klebsiella pneumoniae. Acta Microbiol Immunol Hung 64, 6369 (2017).

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 3.

    Barber, A. E., Norton, J. P., Spivak, A. M., Mulvey, M. A.: Urinary tract infections: Current and emerging management strategies. Clin Infect Dis 57, 719724 (2013).

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 4.

    Heidary, M., Bahramian, A., Goudarzi, H., Eslami, G., Hashemi, A., Khoshnood, S.: To study the association between AcrAB and Qep A efflux pumps and ciprofloxacin resistance among Escherichia coli and Klebsiella pneumoniae clinical strains. Arak Med Univ J 19, 110 (2016).

    • Search Google Scholar
    • Export Citation
  • 5.

    Sallem, R. B., Slama, K. B., Estepa, V., Jouini, A., Gharsa, H., Klibi, N., Saenz, Y., Ruiz-Larrea, F., Boudabous, A., Torres, C.: Prevalence and characterisation of extended-spectrum beta-lactamase (ESBL)-producing Escherichia coli isolates in healthy volunteers in Tunisia. Eur J Clin Microbiol Infect Dis 31, 15111516 (2012).

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 6.

    Jones, G. L., Warren, R., Skidmore, S., Davies, V., Gibreel, T., Upton, M.: Prevalence and distribution of plasmid-mediated quinolone resistance genes in clinical isolates of Escherichia coli lacking extended-spectrum β-lactamases. J Antimicrob Chemother 62, 12451251 (2008).

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 7.

    Roshani, M., Heidary, M., Goudarzi, H., Hashemi, A., Eslami, G., Yousefi, N.: Investigating the antibacterial effect of methanol and acetone extracts of Urtica dioica and Zataria multiflora against metallo beta-lactamase producing Pseudomonas aeruginosa. J Ilam Uni Med Sci 24, 7078 (2016).

    • Search Google Scholar
    • Export Citation
  • 8.

    Karisik, E., Ellington, M., Pike, R., Warren, R., Livermore, D., Woodford, N.: Molecular characterization of plasmids encoding CTX-M-15 β-lactamases from Escherichia coli strains in the United Kingdom. J Antimicrob Chemother 58, 665668 (2006).

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 9.

    Goudarzi, H., Hashemi, A., Fatemeh, F., Noori, M., Erfanimanesh, S., Yosefi, N., Heidary, M., Koshnood, S., Houri, H. R.: Detection of blaDIM, blaAIM, blaGIM, blaNDM and blaVIM genes among Acinetobacter baumannii strains isolated from hospitalized patients in Tehran hospitals, Iran. Iran J Med Microbiol 9, 3239 (2016).

    • Search Google Scholar
    • Export Citation
  • 10.

    Heidary, M., Hashemi, A., Goudarzi, H., Khoshnood, S., Roshani, M., Azimi, H., Goudarzi, M.: The antibacterial activity of Iranian plants extracts against metallo beta-lactamase producing Pseudomonas aeruginosa strains. J Paramed Sci 7, 1319 (2016).

    • Search Google Scholar
    • Export Citation
  • 11.

    Mendonça, N., Leitão, J., Manageiro, V., Ferreira, E., Caniça, M.: Spread of extended-spectrum β-lactamase CTX-M-producing Escherichia coli clinical isolates in community and nosocomial environments in Portugal. Antimicrob Agents Chemother 51, 19461955 (2007).

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 12.

    Yan, J. J., Ko, W. C., Jung, Y. C., Chuang, C. L., Wu, J. J.: Emergence of Klebsiella pneumoniae isolates producing inducible DHA-1 β-lactamase in a university hospital in Taiwan. J Clin Microbiol 40, 31213126 (2002).

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 13.

    Ho, P. L., Chan, J., Lo, W. U., Lai, E. L., Cheung, Y. Y., Lau, T. C., Chow, K. H.: Prevalence and molecular epidemiology of plasmid-mediated fosfomycin resistance genes among blood and urinary Escherichia coli isolates. J Med Microbiol 62, 17071713 (2013).

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 14.

    Mendes, A. C., Rodrigues, C., Pires, J., Amorim, J., Ramos, M. H., Novais, Â., Peixe, L.: Importation of fosfomycin resistance fosA3 gene to Europe. Emerg Infect Dis 22, 346348 (2016).

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 15.

    Sato, N., Kawamura, K., Nakane, K., Wachino, J. I., Arakawa, Y.: First detection of fosfomycin resistance gene fosA3 in CTX-M-producing Escherichia coli isolates from healthy individuals in Japan. Microb Drug Resist 19, 477482 (2013).

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 16.

    Lee, S. Y., Park, Y. J., Yu, J. K., Jung, S., Kim, Y., Jeong, S. H., Arakawa, Y.: Prevalence of acquired fosfomycin resistance among extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae clinical isolates in Korea and IS26-composite transposon surrounding fosA3. J Antimicrob Chemother 67, 28432847 (2012).

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 17.

    Hou, J., Huang, X., Deng, Y., He, L., Yang, T., Zeng, Z., Chen, Z., Liu, J. H.: Dissemination of fosfomycin resistance gene fosA3 with CTX-M β-lactamase genes and rmtB carried on IncFII plasmids among Escherichia coli isolates from pets in China. Antimicrob Agents Chemother 56, 21352138 (2012).

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 18.

    Ho, P., Chan, J., Lo, W., Law, P., Li, Z., Lai, E., Chow, K. H.: Dissemination of plasmid-mediated fosfomycin resistance fosA3 among multidrug-resistant Escherichia coli from livestock and other animals. J Appl Microbiol 114, 695702 (2013).

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 19.

    Wachino, J., Yamane, K., Suzuki, S., Kimura, K., Arakawa, Y.: Prevalence of fosfomycin resistance among CTX-M-producing Escherichia coli clinical isolates in Japan and identification of novel plasmid-mediated fosfomycin-modifying enzymes. Antimicrob Agents Chemother 54, 30613064 (2010).

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 20.

    Heidary, M., Goudarzi, H., Hashemi, A., Eslami, G., Goudarzi, M., Chirani, A. S., Amraei, S.: Prevalence of quinolone resistance genes in Klebsiella pneumoniae strains isolated from hospitalized patients during 2013–2014. Arch Pediatr Infect Dis, e38343 (2016). doi:10.5812/pedinfect.38343 [Epub Ahead of Print].

    • Search Google Scholar
    • Export Citation
  • 21.

    Clinical and Laboratory Standards Institute (CLSI): Performance Standard for Antimicrobial Susceptibility Testing; Seventeenth Informational Supplement. CLSI document M100_s17. CLSI, Wayne, PA, USA, 2013.

    • Search Google Scholar
    • Export Citation
  • 22.

    Lob, S. H., Nicolle, L. E., Hoban, D. J., Kazmierczak, K. M., Badal, R. E., Sahm, D. F.: Susceptibility patterns and ESBL rates of Escherichia coli from urinary tract infections in Canada and the United States, SMART 2010–2014. Diagn Microbiol Infect Dis 85, 459465 (2016).

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 23.

    Shayan, S., Bokaeian, M., Shahraki, S.: Prevalence and molecular characterization of AmpC-producing clinical isolates of Escherichia coli from Southeastern Iran. Microb Drug Resist 20, 104107 (2014).

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 24.

    Saffar, H., Niaraki, N. A., Tali, A. G., Baseri, Z., Abdollahi, A., Yalfani, R.: Prevalence of AmpC β-lactamase in clinical isolates of Escherichia coli, Klebsiella spp., and Proteus mirabilis in a Tertiary Hospital in Tehran, Iran. Jundishapur J Microbiol 9, e39121 (2016).

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 25.

    Domokos, J., Kristóf, K., Szabó, D.: Plasmid-mediated quinolone resistance among extended-spectrum beta-lactamase producing Enterobacteriaceae from bloodstream infections. Acta Microbiol Immunol Hung 63, 313323 (2016).

    • Crossref
    • Search Google Scholar
    • Export Citation

 

The author instruction is available in PDF.
Please, download the file from HERE

Senior editors

Editor-in-Chief: Prof. Dóra Szabó (Institute of Medical Microbiology, Semmelweis University, Budapest, Hungary)

Managing Editor: Dr. Béla Kocsis (Institute of Medical Microbiology, Semmelweis University, Budapest, Hungary)

Co-editor: Dr. Andrea Horváth (Institute of Medical Microbiology, Semmelweis University, Budapest, Hungary)

Editorial Board

  • Prof. Éva ÁDÁM (Institute of Medical Microbiology, Semmelweis University, Budapest, Hungary)
  • Prof. Sebastian AMYES (Department of Medical Microbiology, University of Edinburgh, Edinburgh, UK.)
  • Dr. Katalin BURIÁN (Institute of Clinical Microbiology University of Szeged, Szeged, Hungary; Department of Medical Microbiology and Immunobiology, University of Szeged, Szeged, Hungary.)
  • Dr. Orsolya DOBAY (Institute of Medical Microbiology, Semmelweis University, Budapest, Hungary)
  • Prof. Ildikó Rita DUNAY (Institute of Inflammation and Neurodegeneration, Medical Faculty, Otto-von-Guericke University, Magdeburg, Germany; Center for Behavioral Brain Sciences (CBBS), Magdeburg, Germany)
  • Prof. Levente EMŐDY(Department of Medical Microbiology and Immunology, University of Pécs, Pécs, Hungary.)
  • Prof. Anna ERDEI (Department of Immunology, Eötvös Loránd University, Budapest, Hungary, MTA-ELTE Immunology Research Group, Eötvös Loránd University, Budapest, Hungary.)
  • Prof. Éva Mária FENYŐ (Division of Medical Microbiology, University of Lund, Lund, Sweden)
  • Prof. László FODOR (Department of Microbiology and Infectious Diseases, University of Veterinary Medicine, Budapest, Hungary)
  • Prof. József KÓNYA (Department of Medical Microbiology, University of Debrecen, Debrecen, Hungary)
  • Prof. Yvette MÁNDI (Department of Medical Microbiology and Immunobiology, University of Szeged, Szeged, Hungary)
  • Prof. Károly MÁRIALIGETI (Department of Microbiology, Eötvös Loránd University, Budapest, Hungary)
  • Prof. János MINÁROVITS (Department of Oral Biology and Experimental Dental Research, University of Szeged, Szeged, Hungary)
  • Prof. Béla NAGY (Centre for Agricultural Research, Institute for Veterinary Medical Research, Budapest, Hungary.)
  • Prof. István NÁSZ (Institute of Medical Microbiology, Semmelweis University, Budapest, Hungary)
  • Prof. Kristóf NÉKÁM (Hospital of the Hospitaller Brothers in Buda, Budapest, Hungary.)
  • Dr. Eszter OSTORHÁZI (Institute of Medical Microbiology, Semmelweis University, Budapest, Hungary)
  • Prof. Rozália PUSZTAI (Department of Medical Microbiology and Immunobiology, University of Szeged, Szeged, Hungary)
  • Prof. Peter L. RÁDY (Department of Dermatology, University of Texas, Houston, Texas, USA)
  • Prof. Éva RAJNAVÖLGYI (Department of Immunology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary)
  • Prof. Ferenc ROZGONYI (Institute of Laboratory Medicine, Semmelweis University, Budapest, Hungary)
  • Prof. Zsuzsanna SCHAFF (2nd Department of Pathology, Semmelweis University, Budapest, Hungary)
  • Prof. Joseph G. SINKOVICS (The Cancer Institute, St. Joseph’s Hospital, Tampa, Florida, USA)
  • Prof. Júlia SZEKERES (Department of Medical Biology, University of Pécs, Pécs, Hungary.)
  • Prof. Mária TAKÁCS (National Reference Laboratory for Viral Zoonoses, National Public Health Center, Budapest, Hungary.)
  • Prof. Edit URBÁN (Department of Medical Microbiology and Immunology University of Pécs, Pécs, Hungary; Institute of Translational Medicine, University of Pécs, Pécs, Hungary.)

 

Editorial Office:
Akadémiai Kiadó Zrt.
Budafoki út 187-187, A/3, H-1117 Budapest, Hungary

Editorial Correspondence:
Acta Microbiologica et Immunologica Hungarica
Institute of Medical Microbiology
Semmelweis University
P.O. Box 370
H-1445 Budapest, Hungary
Phone: + 36 1 459 1500 ext. 56101
Fax: (36 1) 210 2959
E-mail: amih@med.semmelweis-univ.hu

 Indexing and Abstracting Services:

  • Biological Abstracts
  • BIOSIS Previews
  • CAB Abstracts
  • Chemical Abstracts
  • Global Health
  • Index Medicus
  • Index Veterinarius
  • Medline
  • Referativnyi Zhurnal
  • SCOPUS
  • Science Citation Index Expanded
2020  
Total Cites 662
WoS
Journal
Impact Factor
2,048
Rank by Immunology 145/162(Q4)
Impact Factor Microbiology 118/137 (Q4)
Impact Factor 1,904
without
Journal Self Cites
5 Year 0,671
Impact Factor
Journal  0,38
Citation Indicator  
Rank by Journal  Immunology 146/174 (Q4)
Citation Indicator  Microbiology 120/142 (Q4)
Citable 42
Items
Total 40
Articles
Total 2
Reviews
Scimago 28
H-index
Scimago 0,439
Journal Rank
Scimago Immunology and Microbiology (miscellaneous) Q4
Quartile Score Medicine (miscellaneous) Q3
Scopus 438/167=2,6
Scite Score  
Scopus General Immunology and Microbiology 31/45 (Q3)
Scite Score Rank  
Scopus 0,760
SNIP
Days from  225
sumbission
to acceptance
Days from  118
acceptance
to publication
Acceptance 19%
Rate

2019  
Total Cites
WoS
485
Impact Factor 1,086
Impact Factor
without
Journal Self Cites
0,864
5 Year
Impact Factor
1,233
Immediacy
Index
0,286
Citable
Items
42
Total
Articles
40
Total
Reviews
2
Cited
Half-Life
5,8
Citing
Half-Life
7,7
Eigenfactor
Score
0,00059
Article Influence
Score
0,246
% Articles
in
Citable Items
95,24
Normalized
Eigenfactor
0,07317
Average
IF
Percentile
7,690
Scimago
H-index
27
Scimago
Journal Rank
0,352
Scopus
Scite Score
320/161=2
Scopus
Scite Score Rank
General Immunology and Microbiology 35/45 (Q4)
Scopus
SNIP
0,492
Acceptance
Rate
16%

 

Acta Microbiologica et Immunologica Hungarica
Publication Model Online only Hybrid
Submission Fee none
Article Processing Charge 1100 EUR/article
Regional discounts on country of the funding agency World Bank Lower-middle-income economies: 50%
World Bank Low-income economies: 100%
Further Discounts Editorial Board / Advisory Board members: 50%
Corresponding authors, affiliated to an EISZ member institution subscribing to the journal package of Akadémiai Kiadó: 100%
Subscription fee 2021 Online subsscription: 652 EUR / 812 USD
Subscription fee 2022 Online subsscription: 662 EUR / 832 USD
Print + online subscription: 740 EUR / 930 USD
Subscription Information Online subscribers are entitled access to all back issues published by Akadémiai Kiadó for each title for the duration of the subscription, as well as Online First content for the subscribed content.
Purchase per Title Individual articles are sold on the displayed price.

Acta Microbiologica et Immunologica Hungarica
Language English
Size A4
Year of
Foundation
1954
Publication
Programme
2021 Volume 68
Volumes
per Year
1
Issues
per Year
4
Founder Magyar Tudományos Akadémia
Founder's
Address
H-1051 Budapest, Hungary, Széchenyi István tér 9.
Publisher Akadémiai Kiadó
Publisher's
Address
H-1117 Budapest, Hungary 1516 Budapest, PO Box 245.
Responsible
Publisher
Chief Executive Officer, Akadémiai Kiadó
ISSN 1217-8950 (Print)
ISSN 1588-2640 (Online)

Monthly Content Usage

Abstract Views Full Text Views PDF Downloads
Apr 2021 1 0 0
May 2021 14 0 0
Jun 2021 6 0 0
Jul 2021 5 0 0
Aug 2021 3 0 0
Sep 2021 4 0 0
Oct 2021 0 0 0